Imaging tau pathology in Alzheimer’s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Imaging tau pathology in Alzheimer’s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies ; volume:17 ; number:1 ; day:3 ; month:6 ; year:2022 ; pages:1-5 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (3.6.2022), 1-5, 12.2022
- Creator
-
Moscoso, Alexis
Wren, Melissa C.
Lashley, Tammaryn
Arstad, Erik
Murray, Melissa E.
Fox, Nick C.
Sander, Kerstin
Schöll, Michael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-022-00543-x
- URN
-
urn:nbn:de:101:1-2022080222012074465197
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moscoso, Alexis
- Wren, Melissa C.
- Lashley, Tammaryn
- Arstad, Erik
- Murray, Melissa E.
- Fox, Nick C.
- Sander, Kerstin
- Schöll, Michael
- SpringerLink (Online service)
Other Objects (12)
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer′s Disease Studies
Amyloid PET imaging: applications beyond Alzheimer’s disease
Quantitative multimodal multiparametric imaging in Alzheimer’s disease
Neuropathology of the Alzheimer's continuum: an update
Imaging endpoints for clinical trials in Alzheimer’s disease
Metabolic imaging in Alzheimer´s Disease using NADH autofluorescence
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
Imaging, cerebral topography and Alzheimer's disease
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer′s Disease Studies
Amyloid PET imaging: applications beyond Alzheimer’s disease
Quantitative multimodal multiparametric imaging in Alzheimer’s disease
Neuropathology of the Alzheimer's continuum: an update
Imaging endpoints for clinical trials in Alzheimer’s disease
Metabolic imaging in Alzheimer´s Disease using NADH autofluorescence
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
Imaging, cerebral topography and Alzheimer's disease
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer′s Disease Studies
Amyloid PET imaging: applications beyond Alzheimer’s disease
Quantitative multimodal multiparametric imaging in Alzheimer’s disease
Neuropathology of the Alzheimer's continuum: an update
Imaging endpoints for clinical trials in Alzheimer’s disease
Metabolic imaging in Alzheimer´s Disease using NADH autofluorescence
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation